Mamitaro Ohtsuki

Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis

Kenneth B. Gordon, Andrew Blauvelt, Kim Papp et al. · New England Journal of Medicine · 2016 · 818 citations · Full text

Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials

Kenneth B. Gordon, Bruce Strober, Mark Lebwohl et al. · The Lancet · 2018 · 627 citations

Autoimmune Disease, Medicine, Clinical Trials +6

Guidelines for management of atopic dermatitis

Hidehisa Saeki, Masutaka Furue, Fukumi Furukawa et al. · The Journal of Dermatology · 2009 · 264 citations · Full text

Antitumor Activity of IFN-λ in Murine Tumor Models

Atsuko Sato, Mamitaro Ohtsuki, Megumi Hata et al. · The Journal of Immunology · 2006 · 192 citations

Epidermal growth factor and transforming growth factor alpha specifically induce the activation- and hyperproliferation-associated keratins 6 and 16.

Chuan-Kui Jiang, Thierry Magnaldo, Mamitaro Ohtsuki et al. · Proceedings of the National Academy of Sciences · 1993 · 189 citations · Full text

Epidermal Growth Factor, Hyperproliferation-associated Keratins 6, Cell Proliferation +18